The Drug-Induced Respiratory Disease Website
Philippe Camus, M.D.
Browse by »
Vascular/capillary leak syndrome (CLS) (see also under Xr)
No description available.
Last update :
No medias available.
A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia.
British journal of haematology 2011;154;471-6 2011
A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy.
Blood 1993;82;2624-33 1993
Phase I immunotoxin trial in patients with B-cell lymphoma.
Cancer research 1991;51;4052-8 1991
Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administration.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1995;18;231-41 1995
Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5;3906-13 1999